Jose Medina-Pestana
Overview
Explore the profile of Jose Medina-Pestana including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
341
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Leite G, Sousa M, Rodrigues L, Brunialti M, Medina-Pestana J, Butler J, et al.
Front Immunol
. 2024 Dec;
15:1508110.
PMID: 39737170
The COVID-19 pandemic has significantly impacted global health, especially in vulnerable populations like kidney transplant recipients (KTRs). Recently, mass spectrometry-based proteomics has emerged as a powerful tool to shed light...
2.
Peereboom E, de Marco R, Geneugelijk K, Jairam J, Verduyn Lunel F, Blok A, et al.
HLA
. 2024 Oct;
104(4):e15719.
PMID: 39435970
Cytomegalovirus (CMV) infection is related to acute rejection and graft loss after kidney transplantation, though the underlying mechanism remains largely unknown. Some CMV strains produce a peptide that is identical...
3.
Mansur J, Chang-Davila D, Simoes M, Cristelli M, Stopa Martins S, Machado de Sousa Proenca H, et al.
Transplant Direct
. 2024 May;
10(6):e1651.
PMID: 38817628
Background: There is no consensus on the ideal strategy to treat posttransplant focal segmental glomerulosclerosis. The multiple-target therapy, which consisted of high-dose intravenous cyclosporine, prednisone, and plasmapheresis, showed favorable results....
4.
Custodio L, Stopa Martins S, Viana L, Cristelli M, Requiao-Moura L, Chow C, et al.
Pediatr Transplant
. 2024 Mar;
28(3):e14713.
PMID: 38553819
Background: This study aimed to compare the efficacy and safety of basiliximab (BAS) versus a single dose of anti-thymocyte globulin (r-ATG) induction therapy in pediatric kidney transplant recipients (KTRs). Methods:...
5.
Silva B, Macedo F, Hayano E, Germano S, Ribeiro I, Franco C, et al.
J Bras Nefrol
. 2024 Jan;
46(2):e20230014.
PMID: 38284551
Introduction: Anemia is frequent in patients undergoing replacement therapy for kidney failure. Anemia in the pre- and post-transplantation period might be related to kidney transplant outcomes. The current study therefore...
6.
Cristelli M, Fortaleza C, Pereira J, Taddeo J, Viana L, Requiao-Moura L, et al.
Transpl Infect Dis
. 2023 Nov;
26(1):e14204.
PMID: 38010722
Background: Because COVID-19 has been associated with high lethality rates among kidney transplant recipients (KTR), but also with a severe disruption and delays in overall healthcare, this study aims to...
7.
Brunialti M, Leite G, Eburneo G, de Araujo O, Pecanha-Pietrobom P, Ferreira P, et al.
Viruses
. 2023 Nov;
15(11).
PMID: 38005844
COVID-19's severity has been associated with a possible imbalance in the cross-regulation of cytokines and vascular mediators. Since the beginning of the pandemic, kidney transplant recipients (KTRs) have been identified...
8.
Amorim C, Cazetta G, Cristelli M, Requiao-Moura L, da Silva E, Pinheiro Vale L, et al.
Transplantation
. 2023 Nov;
108(4):963-969.
PMID: 37953468
Background: Omicron variant has been associated with milder cases of COVID-19 among kidney transplant recipients. However, little is known about postacute sequelae, referred to as Long COVID. Methods: Prospective, single-center...
9.
de Marco R, Monteiro F, Requiao-Moura L, Medina-Pestana J, Gerbase-DeLima M
Transplantation
. 2023 Sep;
107(10):e269-e270.
PMID: 37749814
No abstract available.
10.
Fazio M, Cristelli M, Tomimori J, Koga C, Ogawa M, Beneventi G, et al.
J Bras Nefrol
. 2023 Aug;
45(4):480-487.
PMID: 37565728
Introduction: Previous research demonstrated benefits of late conversion to mTOR inhibitors against cutaneous squamous cell carcinomas (cSCC) in kidney transplant recipients (KTR), despite of poor tolerability. This study investigated whether...